Literature DB >> 23518396

Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls.

Zhiqun Shang, Shimiao Zhu, Hui Zhang, Lihua Li, Yuanjie Niu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23518396     DOI： 10.1016/j.eururo.2013.03.007

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  19 in total

1.  Validation of a Semiautomated Natural Language Processing-Based Procedure for Meta-Analysis of Cancer Susceptibility Gene Penetrance.

Authors:  Zhengyi Deng; Kanhua Yin; Yujia Bao; Victor Diego Armengol; Cathy Wang; Ankur Tiwari; Regina Barzilay; Giovanni Parmigiani; Danielle Braun; Kevin S Hughes
Journal:  JCO Clin Cancer Inform       Date:  2019-08

2.  Heritability of prostate cancer: a tale of rare variants and common single nucleotide polymorphisms.

Authors:  Xifeng Wu; Jian Gu
Journal:  Ann Transl Med       Date:  2016-05

3.  Familial prostate cancer.

Authors:  Veda N Giri; Jennifer L Beebe-Dimmer
Journal:  Semin Oncol       Date:  2016-08-18       Impact factor: 4.929

4.  The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.

Authors:  Jennifer L Beebe-Dimmer; Matthew Hathcock; Cecilia Yee; Linda A Okoth; Charles M Ewing; William B Isaacs; Kathleen A Cooney; Stephen N Thibodeau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-24       Impact factor: 4.254

5.  Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer.

Authors:  Julie L Boyle; Andrew W Hahn; Ashley L Kapron; Wendy Kohlmann; Samantha E Greenberg; Timothy J Parnell; Craig C Teerlink; Benjamin L Maughan; Bing-Jian Feng; Lisa Cannon-Albright; Neeraj Agarwal; Kathleen A Cooney
Journal:  JCO Precis Oncol       Date:  2020-03-04

6.  Two-gene expression ratio as predictor for breast cancer treated with tamoxifen: evidence from meta-analysis.

Authors:  Lin Zhao; Shimiao Zhu; Ying Gao; Yaogang Wang
Journal:  Tumour Biol       Date:  2013-11-22

7.  Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.

Authors:  Jennifer L Beebe-Dimmer; William B Isaacs; Kimberly A Zuhlke; Cecilia Yee; Patrick C Walsh; Sarah D Isaacs; Anna M Johnson; Charles E Ewing; Elizabeth B Humphreys; Wasim H Chowdhury; James E Montie; Kathleen A Cooney
Journal:  BJU Int       Date:  2014-03-05       Impact factor: 5.588

Review 8.  A Review of Prostate Cancer Genome-Wide Association Studies (GWAS).

Authors:  Sarah Benafif; Zsofia Kote-Jarai; Rosalind A Eeles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-01-18       Impact factor: 4.254

9.  Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.

Authors:  Thomas J Hoffmann; Lori C Sakoda; Ling Shen; Eric Jorgenson; Laurel A Habel; Jinghua Liu; Mark N Kvale; Maryam M Asgari; Yambazi Banda; Douglas Corley; Lawrence H Kushi; Charles P Quesenberry; Catherine Schaefer; Stephen K Van Den Eeden; Neil Risch; John S Witte
Journal:  PLoS Genet       Date:  2015-01-28       Impact factor: 5.917

10.  Inherited Mutations in Men Undergoing Multigene Panel Testing for Prostate Cancer: Emerging Implications for Personalized Prostate Cancer Genetic Evaluation.

Authors:  Veda N Giri; Elias Obeid; Laura Gross; Lisa Bealin; Colette Hyatt; Sarah E Hegarty; Susan Montgomery; Andrea Forman; Ruth Bingler; William K Kelly; Adam P Dicker; Stephanie Winheld; Edouard J Trabulsi; David Y T Chen; Costas D Lallas; Brian A Allen; Mary B Daly; Leonard G Gomella
Journal:  JCO Precis Oncol       Date:  2017-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.